Related Experiment Video
Updated: May 8, 2026
Contrast Ultrasound Targeted Treatment of Gliomas in Mice via Drug-Bearing Nanoparticle Delivery and Microvascular Ablation
Published on: December 15, 2010
Ultrasmall solid lipid nanoparticles as a potential innovative delivery system for a drug combination against glioma
Luigi Battaglia1,2, Chiara Dianzani1, Elisabetta Muntoni1
1Department of Drug Science and Technology, University of Turin, Turin, Italy.
Introduction:
High grade gliomas are characterized by a very poor prognosis due to fatal relapses after surgery. Current chemotherapy is only a palliative care, while potential drug candidates are limited by poor overcoming of the blood-brain barrier.
Aims:
A suitable chemotherapeutic approach should be engineered to overcome both the altered blood-brain barrier in the glioma site, as well as the intact one in the brain adjacent to tumor zone, and to target the multiple factors influencing glioma proliferation, differentiation, migration, and angiogenesis.
Materials & Methods:
In this experimental research, ultrasmall solid lipid nanoparticles were prepared owing to the temperature phase inversion technology and loaded with a specific drug combination made of paclitaxel, regorafenib, and nanoceria.
Results:
Such solid lipid nanoparticles demonstrated capability to inhibit glioma cell proliferation and migration, as well as angiogenesis in vitro. Moreover, relevant in vivo evidence assessed the accumulation of solid lipid nanoparticles in the glioma site of the F98/Fischer rat model, without causing any off-target toxicity.
Conclusions:
Thus, promising results for glioma treatment were obtained with a technology characterized by safety and economy, allowing the perspective of successful scalability.
Insights
Ultrasmall solid lipid nanoparticles effectively target high-grade gliomas, inhibiting proliferation and angiogenesis. This safe and economical nanotechnology shows promise for future glioma treatment by overcoming blood-brain barrier challenges.
Area of Science:
- Nanotechnology
- Oncology
- Biomedical Engineering
Background:
- High-grade gliomas have a poor prognosis with limited chemotherapy options due to the blood-brain barrier.
- Effective glioma treatment requires overcoming both the altered and intact blood-brain barrier.
- Targeting multiple glioma progression factors like proliferation, differentiation, migration, and angiogenesis is crucial.
Purpose of the Study:
- To develop and evaluate ultrasmall solid lipid nanoparticles for high-grade glioma treatment.
- To engineer nanoparticles capable of crossing the blood-brain barrier and targeting glioma cells.
- To assess the efficacy and safety of a novel drug combination delivered via nanoparticles.
Main Methods:
- Ultrasmall solid lipid nanoparticles were prepared using temperature phase inversion technology.
- Nanoparticles were loaded with a combination of paclitaxel, regorafenib, and nanoceria.
- In vitro and in vivo studies were conducted using glioma cell lines and a rat glioma model.
Main Results:
- Solid lipid nanoparticles inhibited glioma cell proliferation and migration in vitro.
- Angiogenesis was also inhibited by the nanoparticles in vitro.
- In vivo studies demonstrated nanoparticle accumulation at the glioma site without off-target toxicity in a rat model.
Conclusions:
- The developed ultrasmall solid lipid nanoparticles show significant promise for treating high-grade gliomas.
- This nanotechnology offers a safe, economical, and scalable approach to overcoming blood-brain barrier limitations.
- The findings support further development of this nanoparticle-based therapy for clinical application.
More Related Videos
07:25Author Spotlight: Multimodal Imaging Strategies for Optimizing Drug Delivery and Early Detection in Glioblastoma Treatment
Published on: March 1, 2024
09:02Author Spotlight: Innovative Cancer Therapies with Iron Oxide Nanoparticles for Glioblastoma Treatment
Published on: September 27, 2024
